Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HTJXN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
TQB2103
|
|||||
| Synonyms |
TQB 2103; TQB-2103
Click to Show/Hide
|
|||||
| Organization |
Nanjing Shunxin Pharmaceutical Co., Ltd.; Sino Biopharmaceutical Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Claudin-18.2 (CLDN18.2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.